Two Sigma Securities’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-39,951
Closed -$286K 2039
2025
Q4
$286K Buy
+39,951
New +$316K 0.04% 651
2025
Q3
Sell
-11,031
Closed -$107K 1842
2025
Q2
$107K Buy
+11,031
New +$114K 0.01% 1036
2024
Q4
Sell
-15,705
Closed -$300K 2746
2024
Q3
$300K Buy
+15,705
New +$326K 0.01% 1747
2024
Q1
Sell
-22,463
Closed -$385K 3442
2023
Q4
$324K Buy
+22,463
New +$306K ﹤0.01% 1928
2023
Q3
Sell
-17,586
Closed -$367K 3315
2023
Q2
$366K Buy
+17,586
New +$382K 0.01% 1705
2022
Q4
Sell
-13,230
Closed -$310K 3067
2022
Q3
$310K Buy
+13,230
New +$399K 0.01% 1544

Other funds holding OGN

Two Sigma Securities's OGN Position: Q1 2026 in Review

Two Sigma Securities sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 39,951 shares — an estimated $286K sold.

Two Sigma Securities first reported a position in OGN in Q3 2022 and held it in 6 quarters. The position peaked at $366K in Q2 2023. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Two Sigma Securities reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 39,951 Organon & Co shares in Q1 2026, an estimated $286K.
  • Two Sigma Securities first reported a position in Organon & Co in Q3 2022 and held it in 6 quarters.
  • Two Sigma Securities's Organon & Co position peaked at $366K in Q2 2023.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.